BSE filing, NSE: ALKA. Summary written from the filing by ALFA Finder's alert engine.
Alka India Ltd: key numbers
- Share price
- ₹31.50
- Market cap
- ₹20.48 Cr
- Revenue (annual)
- ₹2.50 Cr
- Net profit (annual)
- ₹0.18 Cr
- P/E (TTM)
- 32.1×Sector 49.0×
- Promoter holding
- 73.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alka India Ltd
All →AUDROC Other Announcement
Audroc Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
AUDROC Preferential Issue
AUDROC Limited allotted convertible securities via a preferential issue. This allotment changes the company's capital structure as part of its ongoing fund-raising process.
- Value
- ₹80.00 Cr
AUDROC Convertible Warrants
Audroc Ltd allotted 20 crore equity shares upon converting warrants at ₹4.00 per warrant, raising ₹80 Crore capital for the company.
- Value
- ₹80.00 Cr
AUDROC Capital Structure Change
Audroc Ltd has allotted 7.50 crore fully convertible equity warrants to two non-promoter allottees. The warrants were issued at Rs. 4.00 each on a preferential basis.
- Value
- ₹30.00 Cr
- Execution
- 18 months
AUDROC Capital Structure Change
Audroc Ltd has allotted 3,75,00,000 convertible equity warrants on a preferential basis to a non-promoter investor at an issue price of ₹4.00 per warrant. This allotment constitutes a change in capital structure.
- Value
- ₹15.00 Cr
AUDROC Capital Structure Change
Audroc Limited allotted 2.5 crore fully convertible equity warrants on a preferential basis to a promoter group investor at an issue price of Rs 4 per warrant.
- Value
- ₹10.00 Cr
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.